The apex court said that they would hear the Singhs on the quantum of sentence later.

Two of India’s most-famous billionaires,Malvinder Singh and Shivinder Singh -- the former promoters…

But, there is more bad news to come. Now, he is going a bit further to bring in a law wh…

Drug makers in India have relied on Americans to buy a big chunk their produce for a long time now…

The brothers are being investigated for the loss of ₹23 billion from their listed companies,…

India’s Supreme Court has ordered the former promoters of pharma major Ranbaxy, Malvinder Mohan Sin…

The Japanese pharmaceutical company had filed the arbitration case in 2013 in Singapore, in which i…

“The development pertains to only the Company’s cephalosporin injectable unit at Dewas in Madhya Pr…

As per the settlement agreement, Ranbaxy will pay $39.75 million to Texas by August 2015. The claim…

“We have now received a communication from the USFDA that they have determined that Ranbaxy has for…

The stand-alone total income from operations of the company declined 4.4% to Rs 224.43 crore during…

"The second allegation relates to misuse of R&D expenses at Sun Pharma's Sikkim unit, which is …

"A thorough assessment has been made of current overlaps across the organisation. While all attempt…

Another brokerage BoFA ML cut its target on Sun Pharma to `950 from `1,063 while maintainin…

The Economic Times reported that this order comes a year after the Dilip Shanghvi-led firm acquir…

Sun Pharmaceutical Industries today said it is reviewing a complaint filed against it and its subsi…

The regulators said they were satisfied by the corrective measures taken by the company. They also …

In its petition, Ranbaxy said that the FDA had exceeded its jurisdiction by revoking the approvals …

Sun Pharma and Ranbaxy Laboratories announced that they have entered into definitive agreements pur…

While conducting the inspection, the German regulator noticed numerous operation-and-procedured-rel…